ImmuCell(ICCC) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 01-0382980 (State of Incorporation) (I.R.S. Employer Identification No.) Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.10 par value per share ICCC The Nasdaq Capital Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 001-12934 (Commission file number) ImmuCell Corporation ( ...